The pharma business could be spun off down the track and could be listed on the NASDAQ. It's still a long way to go but one day, you never know.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game